Contract Details: 6D08632951
Contract
Vendor Name:
CANGENE CORPORATION
Description:
Pharmaceutical and other medicinal products
Economic Object Code:
1132
Instrument Type:
Amendment
Commodity Type:
Good
Commodity Code:
N6505
Organization:
Public Health Agency of Canada
Comments:
Pharmaceutical and Other Medicinal Products
Additional Comments:
Drugs and Biologicals
Date and Value
Reporting Period:
2021-2022-Q1
Contract Date:
Dec 30, 2013
Contract Period Start Date:
Dec 30, 2013
Contract Period End or Delivery Date:
Jul 31, 2021
Total Contract Value:
$2,344,979.86
Original Contract Value:
$1,123,208.70
Amendment Value:
$375,315.75
Applicable Trade Agreements
| Canadian Free Trade Agreement (CFTA) |
| Canada-Chile Free Trade Agreement (CCFTA) |
| Canada-Colombia Free Trade Agreement (CCoFTA) |
| Canada-Honduras Free Trade Agreement (CHFTA) |
| Canada-Panama Free Trade Agreement (CPaFTA) |
| Canada-Peru Free Trade Agreement (CPFTA) |
| Canada-South Korea Free Trade Agreement (CKFTA) |
| World Trade Organization – Agreement on Government Procurement (WTO-AGP) |
| Comprehensive Economic and Trade Agreement (CETA) |
| Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP) |
Additional Details
Procurement Identification Number:
6D08632951
Solicitation Procedure:
Competitive – Traditional
Limited Tendering Reason:
None
Trade Agreement Exceptions and Exclusions:
None
Comprehensive Land Claims Agreement:
-
Indigenous Business excluding PSIB:
No
Intellectual Property:
Contractor Owned
Potential Commercial Exploitation:
No
Former Public Servant:
No
Ministers Office Contracts:
No
Country of Vendor:
Canada
Article 6 Government Contract Exceptions:
-